·病例报道·恶性子宫血管周上皮样细胞肿瘤1例并文献复习

doi:10.6040/j.issn.1671-7554.0.2018.322

摘要/Abstract

中图分类号:

R737.33

李娜,代聪伟. ·病例报道·恶性子宫血管周上皮样细胞肿瘤1例并文献复习[J]. 山东大学学报 (医学版), 2018, 56(5): 93-96.

[1] Zhang C, Pan F, Qiao J, et al. Perivascular epithelioid cell tumor of the cervix with malignant potential[J]. Int J Gynecol Obstet, 2013, 123(1):72-73.
[2] Azad NS, Aziz AB, Pervez S, et al. Uterine perivascular epithelioid cell tumour presenting as a cervical mass[J]. J Pak Med Assoc, 2006, 56(2): 83-84.
[3] Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature[J]. Am J Surg Pathol, 2005, 29(12): 1558-1575.
[4] Fadare O, Parkash V, Yilmaz Y, et al. Perivascular epithelioid cell tumor(PEComa)of the uterine cervix associated with intraabdominal “PEComatosis”: a clinicopathological study with comparative genomic hybridization analysis[J]. World J Surg Oncol, 2004, 2: 35-46.
[5] Kalyanasundaram K, Parameswaran A, Mani R. Perivascular epithelioid tumor of urinary bladder and vagina[J]. Ann Diagn Pathol, 2005, 9(5): 275-278.
[6] Natella V, Merolla F, Giampaolino P, et al. A huge malignant perivascular epithelioid cell tumor(PEComa)of the uterine cervix and vagina[J]. Pathol Res Pract, 2014, 210(3): 186-188.
[7] Mentzel T, Reisshauer S, Rutten A, et al. Cutaneous clear cell myomelanocytic tumour: a new member of the growing family of perivascular epithelioid cell tumours(PEComas). Clinicopathological and immunohistochemical analysis of seven cases[J]. Histopathology, 2005, 46(5): 498-504.
[8] Fink D, Marsden DE, Edwards L, et al. Malignant perivascular epithelioid cell tumor(PEComa)arising in the broad ligament[J]. Int J Gynecol Cancer, 2004, 14(5): 1036-1039.
[9] Kim HJ, Lim SJ, Choi H, et al. Malignant clear-cell myomelanocytic tumor of broad ligament—a case report[J]. Virchows Arch, 2006, 448(6): 867-870.
[10] Sikora-Szczesniak DL. PEComa of the uterus—a case report[J]. Ginekol Pol, 2013, 84(3): 234-236.
[11] Bonetti F, Martignoni G, Colato C, et al. Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosis[J]. Mod Pathol, 2001, 14(6): 563-568.
[12] Zamboni G, Pea M, Martignoni G, et al. Clear cell “sugar” tumor of the pancreas: a novel member of the family of lesions characterized by the presence of perivascular epithelioid cells[J]. Am J Surg Pathol, 1996, 20(6):722-730.
[13] Folpe AL. Neoplasms with perivascular epithelioid cell difierentiation(PEComas)[M] // F1etcher CD, Unni KK, Mertens F, et al. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002: 221-222.
[14] Thway K, Fisher C. PEComa: morphology and genetics of a complex tumor family[J]. Ann Diagn Pathol, 2015, 19(5): 359-368.
[15] Dibble CC, Cantley LC. Regulation of mTORC1 by PI3K signaling[J]. Trends Cell Biol, 2015, 25(9): 545-555.
[16] Agaram NP, Sung YS, Zhang L, et al. Dichotomy of genetic abnormalities in PEComas with therapeutic implications[J]. Am J Surg Pathol, 2015, 39(6):813-825.
[17] Kwon BS, Suh DS, Lee NK, et al. Two cases of perivascular epithelioid cell tumor of the uterus: clinical, radiological and pathological diagnostic challenge[J]. Eur J Med Res, 2017, 22(1): 7.
[18] Vang R, Kempson RL. Perivascular epithelioid cell tumor(‘PEComa’)of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors[J]. Am J Surg Pathol, 2002, 26(1): 1-13.
[19] Starbuck KD, Drake RD, Budd GT, et al. Treatment of advanced malignant uterine perivascular epithelioid cell tumor with mTOR inhibitors: single-institution experience and review of the literature[J]. Anticancer Res, 2016, 36(11): 6161-6164.
[20] 刘飞飞,饶秋,张仁亚,等.伴有TFE3 扩增的宫颈血管周上皮样细胞肿瘤[J].临床与实验病理学杂志, 2013, 29(12): 1361-1363.
[21] Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis[J]. Hum Pathol, 2010, 41(1): 1-15.
[22] 罗家寿,罗雪珍,黄雯,等.子宫血管周上皮样细胞肿瘤2例[J].实用妇产科杂志, 2013, 29(7): 558-559.
[23] Choi YJ, Hong JH, Kim A, et al. A case of malignant PEComa of uterus associated with intramural leiomyoma and endometrial carcinoma[J]. J Pathol Transl Med, 2016, 50(6): 469-473.
[24] Jeon IS, Lee SM. Multimodal treatment using surgery, radiotherapy, and chemotherapy in a patient with a perivascular epithelioid cell tumor of the uterus[J]. J Pediatr Hematol Oncol, 2005, 27(12): 681-684.
[25] Bosincu L, Rocca PC, Martignoni G, et al. Perivascular epithelioid cell(PEC)tumors of the uterus: a clinicopathologic study of two cases with aggressive features[J]. Mod Pathol, 2005, 18(10): 1336-1342.
[26] Ruco LP, Pilozzi E, Wedard BM, et al. Epithelioid lymphangioleiomyomatosis-like tumour of the uterus in a patient without tuberous sclerosis: a lesion mimicking epithelioid leiomyosarcoma[J]. Histopathology, 1998, 33(1):91-93.
[27] Fukunaga M. Perivascular epithelioid cell tumor of the uterus: report of four cases[J]. Int J Gynecol Pathol, 2005, 24(4): 341-346.
[28] Bleeker JS, Quevedo JF, Folpe AL. Malignant perivascular epithelioid cell tumor of the uterus[J]. Rare Tumors, 2012, 4(1): e14. doi: 10.4081/rt.2012.e14.
[29] 陈博,王文泽,刘彤华.子宫血管周上皮样细胞肿瘤3例临床病理分析[J].协和医学杂志, 2013, 4(4): 459-461.
[30] Acosta AM,Adley BP. Predicting the behavior of perivascular epithelioid cell tumors of the uterine corpus[J]. Arch Pathol Lab Med, 2017, 141(3): 463-469.
[31] Fadare O. Perivascular epithelioid cell tumor(PEComa)of the uterus: an outcome-based clinicopathologic analysis of 41 reported cases[J]. Adv Anat Pathol, 2008, 15(2): 63-75.
[32] 许丹,徐敏,薛金玲.子宫血管周上皮样细胞肿瘤1例及文献复习[J].南通大学学报(医学版), 2016, 36(1): 84-85.
[33] 胡旦红,刘芳,于亚威.恶性子宫血管周上皮样细胞肿瘤1例[J].实用妇产科杂志, 2012, 28(5): 375-376.

相关文章 15

[1]	王丽慧,高敏,孔北华. 子宫血管肉瘤2例报告并文献复习[J]. 山东大学学报 (医学版), 2022, 60(9): 108-112.
[2]	杨粒芝,孙霄,商蒙蒙,郭鲁,时丹丹,李杰. 基于中国版甲状腺影像报告与数据系统的甲状腺结节恶性风险预测模型[J]. 山东大学学报 (医学版), 2022, 60(6): 64-69.
[3]	程传龙,杨淑霞,佘凯丽,房启迪,韩闯,刘盈,崔峰,李秀君. 淄博市2018年恶性肿瘤的流行特征及影响因素[J]. 山东大学学报 (医学版), 2022, 60(2): 102-108.
[4]	赵洁,李岩,李明,于德新. 螺旋CT对黏液性软组织肿瘤良恶性鉴别的价值[J]. 山东大学学报 (医学版), 2021, 59(4): 100-107.
[5]	陈安静,张训. 靶向小类泛素化修饰的胶质瘤治疗新策略[J]. 山东大学学报 (医学版), 2020, 1(8): 88-94.
[6]	杨佳欣,沈铿,王遥. 妇科恶性肿瘤保留生育功能治疗的现状与展望[J]. 山东大学学报 (医学版), 2018, 56(5): 1-7.
[7]	王瑾晖,杨佳欣,袁振,曹冬焱,沈铿,黄惠芳,吴鸣,潘凌亚,郭丽娜. 复发和未控卵巢恶性生殖细胞肿瘤保留生育功能的治疗[J]. 山东大学学报 (医学版), 2018, 56(5): 35-40.
[8]	董尧,宋亚林,田涛,高建国. 确诊8年未经治疗却无明显进展的阴茎恶性黑色素瘤1例报道[J]. 山东大学学报（医学版）, 2017, 55(3): 125-126.
[9]	申文江. 放射性粒子植入的创新性临床研究[J]. 山东大学学报（医学版）, 2017, 55(2): 1-3.
[10]	王雯,刘尧,龙飞,马卫霞,苏莉莉. 外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系[J]. 山东大学学报（医学版）, 2016, 54(8): 72-77.
[11]	文芳静,史小武. 气道支架置入术治疗恶性气道狭窄伴一侧肺通气的临床研究[J]. 山东大学学报（医学版）, 2016, 54(12): 62-66.
[12]	张颖,林琦,袁苑,戴建建,耿宝成,徐瑞彩,刘亚坤,韩明勇. 3D打印个体化模板联合CT引导¹²⁵I粒子植入治疗恶性肿瘤质量评价[J]. 山东大学学报（医学版）, 2016, 54(11): 44-50.
[13]	于绍轶, 陈远银, 刘海韵, 曲淑娜, 徐颖, 王倩倩, 王茂波. 应用DALYs评价烟台市恶性肿瘤疾病负担[J]. 山东大学学报（医学版）, 2015, 53(8): 92-96.
[14]	张敏, 穆晓楠, 马伟元, 党宁宁, 张楠. 山东省皮肤恶性黑色素瘤患者的临床特征与预后危险因素分析(附61例报告)[J]. 山东大学学报（医学版）, 2015, 53(11): 80-84.
[15]	倪忆媚, 叶丽. 舒适护理在妇产科恶性肿瘤患者中的应用效果[J]. 山东大学学报（医学版）, 2014, 52(Z2): 154-155.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed